Norwegian version of this page

What's on at Norway Life Science Conference 2025

From 11 to 12 February, the Norway Life Science 2025 will take place, with health data and artificial intelligence as the main themes. This year's conference promises to challenge and find solutions for the future, featuring a programme filled with leading experts.

Keynote speakers at Norway Life Science 2025.

Photo of Micaelsen by Torbj?rn Tandberg, of Erna Solberg: Hans Kristian Thorbj?rnsen and of Myrseth: Ministry of Trade, Industry and Fisheries.

– This year, we will highlight how excellent research in artificial intelligence combined with health data can lay the groundwork for better and more efficient healthcare services and treatments, contribute to sustainable welfare for a rapidly aging population, and lead to increased value creation in the health industry. We will also focus on how the Norwegian health industry can become more competitive internationally and how we can attract more investments, says Carl Henrik G?rbitz, Conference Director and Director of UiO:Life Science.

After the opening with Rector Svein St?len and Governing Mayor of Oslo Eirik Lae Solberg, the first speaker on the podium will be Stefan Woxstr?m, Senior Vice President for Europe and Canada at AstraZeneca. He will focus on ?What does investing in Norway involve.? The opening will also feature State Secretary in the Ministry of Digitalization and Public Administration, Torgeir Micaelsen, who will speak about ?Digitalization, AI, and the use of health data as drivers for better healthcare services, outstanding research, and new health industries.?

Three international keynote speakers

On the programme, we have three internationally recognized names as keynote speakers. Timothy Miller, Vice President of Enterprise Science and Innovation at Thermo Fisher Scientific, will take the stage to talk about how they use health data and artificial intelligence in diagnostics and drug development.

Erwin B?ttinger, Director of the Wyss Center for Bio and Neuroengineering in Switzerland, will lead us into the future and share his reflections on how artificial intelligence and technology will revolutionize patient care. Additionally, Patrick Schwab, Senior Director of Machine Learning and Artificial Intelligence, GSK will focus on how artificial intelligence can transform the healthcare sector and benefit both patients and society.

We will also focus on the challenges associated with using health data and what is needed to increase access. This will be the topic of the panel discussion with the leaders of Oslo University Hospital, Trondheim Municipality, the Norwegian Directorate of Health